Development and validation of a machine learning-based predictive model for early outcomes following combined suction-assisted lipectomy and lymphovenous anastomosis in breast cancer-related lymphedema: a retrospective cohort study - Top-Institutions - MDSpire

Development and validation of a machine learning-based predictive model for early outcomes following combined suction-assisted lipectomy and lymphovenous anastomosis in breast cancer-related lymphedema: a retrospective cohort study

  • By

  • Yonghao Cui

  • Hao Dong

  • Zixuan Yao

  • Shuai Pang

  • Yuguang Sun

  • Song Xia

  • Wenbin Shen

  • May 7, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Beijing Shijitan Hospital
    Beijing Shijitan Hospital

    Beijing, Beijing

    Key Differentiators

    • Surgical Oncology

  • #2

    Italian Society of Endoscopic Surgery
    Italian Society of Endoscopic Surgery

    Rome, Lazio

    Key Differentiators

    • Surgical Oncology

  • #3

    Wuhan Union Hospital
    Wuhan Union Hospital

    Wuhan, Hubei

    Key Differentiators

    • Surgical Oncology

Original Source(s)

Development and validation of a machine learning-based predictive model for early outcomes following combined suction-assisted lipectomy and lymphovenous anastomosis in breast cancer-related lymphedema: a retrospective cohort study

  • by Yonghao Cui, Hao Dong, Zixuan Yao, Shuai Pang, Yuguang Sun, Song Xia, Wenbin Shen

  • May 7, 2026

Related Content

One Pathway for Esophageal Cancer?

Molecular profiling reveals precursor signals in BE-negative esophageal cancer

  • May 7, 2026

  • 2 min
Plasma miR-371a-3p Predicts Recurrence in Stage I Testicular Cancer: Interim Results From the CLIMATE Study

In the management of stage I testicular cancer, a persistent clinical dilemma is the identification of patients who truly need adjuvant treatment after orchiectomy rather than active surveillance alon...

‘Promising’ Signal Only: ctDNA in Early Breast Cancer Not Yet Ready for Clinical Use

Despite compelling prognostic associations across multiple retrospective data sets, no interventional trial has demonstrated that acting on circulating tumor DNA testing results in early breast cancer...